SpiderRock Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $409K | Hold |
5,815
| – | – | 0.01% | 495 |
|
2024
Q2 | $479K | Hold |
5,815
| – | – | 0.01% | 423 |
|
2024
Q1 | $487K | Buy |
+5,815
| New | +$487K | 0.01% | 399 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 27 |
|
2023
Q3 | – | Hold |
0
| – | – | – | 26 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 24 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 23 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 24 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 26 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 24 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 20 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 21 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 21 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 22 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 21 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 22 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 23 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 23 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 22 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 21 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 18 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 15 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 350 |
|
2017
Q1 | – | Hold |
0
| – | – | – | 459 |
|